A novel copper(II) complex has been developed in which the counter anion, acylphosphinate, serves as a visible light photoinitiator. This molecule is inactive in the dark but, upon visible light exposure, both CuAAC and ATRP reactions are readily and rapidly initiated.
No takes yet. Share an insight, caveat, or question.
Gong et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: